Jennifer Lentz has been the Global Informed Consent Business Lead at Eli Lilly and Company for the last 4 years. She has been involved in consent projects with Clinical Trials Transformation Initiative, Transcelerate, and Innovative Medicines Initiatives. Prior to joining Lilly, Jennifer worked as a study monitor, study coordinator, disease field investigator, and lab researcher. She became interested in informed consent during her involvement as a pediatric research subject.